Dr. Hecht is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9440 Sw 91st St
Miami, FL 33176Phone+1 305-271-0099Fax+1 305-667-0239
Education & Training
University of Miami/Jackson Health SystemResidency, Radiology-Diagnostic, 1971 - 1975- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1970 - 1971
University of Miami Leonard M. Miller School of MedicineClass of 1970
Certifications & Licensure
FL State Medical License 1973 - 2025- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 332 citationsBleomycin: new perspectives on the mechanism of action.Sidney M. Hecht
Journal of Natural Products. 2000-01-01 - 230 citationsIdentification of the First Specific Inhibitor of p90 Ribosomal S6 Kinase (RSK) Reveals an Unexpected Role for RSK in Cancer Cell ProliferationJeffrey A. Smith, Celeste E. Poteet-Smith, Yaming Xu, Timothy M. Errington, Sidney M. Hecht
Cancer Research. 2005-02-01 - 12 citationsSynthesis and evaluation of verticipyrone analogues as mitochondrial complex I inhibitors.Simon J. Leiris, Omar M. Khdour, Zachary J. Segerman, Krystal S. Tsosie, Jean-Charles Chapuis
Bioorganic & Medicinal Chemistry. 2010-05-15
Grant Support
- Synthesis Of Bleomycin Group Antibiotics And AnaloguesNational Cancer Institute1998–2007
- Elaboration Of Modified Proteins Using Misacylated TrnasNational Cancer Institute1998–2007
- Interaction Of Bleomycin With RNA And DNANational Cancer Institute1998–2006
- Natural Products Discovery - Nuclear And Signaling TargeNational Cancer Institute2000–2004
- Mechanism And Inhibition Of Human DNA Topoisomerase INational Cancer Institute2000–2003
- Nuclear Targets For Natural Products Drug DiscoveryNational Cancer Institute1995–2002
- Core--Preparation, Storage, And Shipping Of Plant Extracts And AssaysNational Cancer Institute1995–2002
- Natural Products Discovery--Nuclear &Signaling TargetsNational Cancer Institute1995–2000
- Natural Prod Discovery--Nuclear &Signaling TargetsNational Cancer Institute1999
- Nucleic Acids As Therapeutic TargetsNational Cancer Institute1991–1997
- Nucleic Acids As Therapeutic Targets: Bleomycin, Antitumor, AntibioticNational Center For Research Resources1996
- Synthesis/Inhibition--P Falciparum DNA Polymerase DeltaNational Institute Of Allergy And Infectious Diseases1995
- Mechanism Based Discovery Of Novel Antitumor AgentsNational Cancer Institute1994
- Synthetic Polypeptides VIA In Vitro Protein BiosynthesisNational Institute Of General Medical Sciences1990–1994
- Dept Chemistry, University Of VirginiaNational Cancer Institute1989–1994
- Mechanism-Based Discovery Of Novel Antitumor AgentsNational Cancer Institute1989–1993
- Chemistry Of Activated BleomycinNational Cancer Institute1988–1991
- Synthesis Of Bleomycin Group AntibioticsNational Cancer Institute1985–1991
- Inhibition Of HIV ExpressionNational Institute Of Allergy And Infectious Diseases1988–1990
- Natural Products That Cleave DNANational Cancer Institute1985–1990
- Purchase Of General Electric Gn-500 NMR SpectrometerNational Center For Research Resources1988
- Nucleotide Replacements In Transfer RNANational Institute Of General Medical Sciences1985–1987
- Chemistry Of Activated BleomycinNational Cancer Institute1985–1987
- Purchase Of Varian Xl-300 NMR SpectrometerNational Center For Research Resources1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
